Bacille Calmette-Guérin (BCG) vaccine and potential cross-protection against SARS-CoV-2 infection — Assumptions, knowns, unknowns and need for developing an accurate scientific evidence base

After a century of controversies on its usefulness in protection against TB, underlying mechanisms of action, and benefits in various groups and geographical areas, the BCG vaccine is yet again a focus of global attention- this time due to the global COVID-19 pandemic caused by the novel severe acut...

Descripción completa

Detalles Bibliográficos
Autores principales: Nachega, Jean B., Maeurer, Markus, Sam-Agudu, Nadia A., Chakaya, Jeremiah, Katoto, Patrick D.M., Zumla, Alimuddin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006492/
https://www.ncbi.nlm.nih.gov/pubmed/33794380
http://dx.doi.org/10.1016/j.ijid.2021.03.060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006492/
https://www.ncbi.nlm.nih.gov/pubmed/33794380
http://dx.doi.org/10.1016/j.ijid.2021.03.060

Ejemplares similares